Services/Regulatory Affairs
Service 01

Regulatory Affairs

Expert guidance through FDA submissions, international regulatory pathways, and lifecycle management — so your products reach market faster, with full compliance and confidence.

Regulatory affairs pharmaceutical documentation
Capabilities

Full-Spectrum Regulatory Support

IND, NDA & BLA Submissions

Expert preparation and management of Investigational New Drug, New Drug Application, and Biologics License Application submissions to the FDA.

International Regulatory Strategy

Navigating EMA, COFEPRIS, and other international regulatory bodies to support global market access for your products.

510(k) & PMA Pathways

Comprehensive support for medical device submissions including 510(k) premarket notifications and Premarket Approval applications.

Pre-Submission Meetings

Strategic preparation and facilitation of FDA pre-submission meetings to align on regulatory expectations before formal submissions.

Regulatory Gap Analysis

Thorough assessment of your current regulatory posture against applicable requirements, with a clear remediation roadmap.

Post-Market Surveillance

Ongoing regulatory support including adverse event reporting, labeling updates, and post-approval change management.

Our Process

A Clear Path from Strategy to Approval

01

Discovery & Assessment

We evaluate your product, target markets, and current regulatory status to define the optimal pathway.

02

Strategy Development

A tailored regulatory strategy is developed, including timelines, resource requirements, and risk mitigation.

03

Submission Preparation

Our team prepares all required documentation, dossiers, and technical files to the highest standard.

04

Agency Interaction

We manage all communications with regulatory agencies, including responses to queries and meeting facilitation.

05

Approval & Beyond

Post-approval support ensures continued compliance through labeling, changes, and lifecycle management.

Regulatory Frameworks We Navigate

Deep expertise across U.S. and international regulatory bodies and standards.

FDA 21 CFR Part 11FDA 21 CFR Part 210/211FDA 21 CFR Part 820ICH Q8/Q9/Q10ICH E6 GCPEMA GuidelinesCOFEPRISISO 14971ISO 13485EU MDR 2017/745PMDA JapanHealth Canada

Ready to accelerate your regulatory pathway?

Our team is ready to assess your needs and outline a clear strategy — in English or Spanish.